Acumen is forging a new path towards safe and effective treatments for Alzheimer’s disease and other neurodegenerative diseases through our focus on the biology of toxic soluble amyloid-beta oligomers.
Our founders pioneered seminal discoveries and methods to understand the role of toxic amyloid-beta oligomers (Aβo) in synaptic dysfunction and neurodegeneration. These early insights have fostered decades of research on the biology of Aβo at Acumen and throughout the field. We are now on the on cusp of realizing the therapeutic potential of Aβo targeted drugs.
Company Details
- Employees
- 68
- Address
- Greater Boston, Ma, Us
- Phone
- 6508757772
- in****@****arm.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- acumenpharm.com
- Keywords
- Alzheimer's disease, Neurodegenerative disease, therapeutics, amyloid-beta oligomers, monoclonal anitbodies, immunotherapy.
- HQ
- Greater Boston, MA
Acumen Pharmaceuticals, Inc. Questions
Acumen Pharmaceuticals, Inc.'s helpline number is 6508757772
Acumen Pharmaceuticals, Inc.'s website is acumenpharm.com
Acumen Pharmaceuticals, Inc.'s LinkedIn profile is https://www.linkedin.com/company/acumen-pharm
Acumen Pharmaceuticals, Inc. has
68 employees.
View email and phone details for 68
employees at Acumen Pharmaceuticals, Inc..
Acumen Pharmaceuticals, Inc.'s industry is
Biotechnology Research
Acumen Pharmaceuticals, Inc.'s top competitors are
Acumen Pharmaceuticals Private Limited,
Acadia Pharmaceuticals Inc.,
Vertex Pharmaceuticals,
Alnylam Pharmaceuticals,
Adial Pharmaceuticals (Nasdaq: Adil),
Acumen Pharma (Pvt.) Ltd,
Syndax Pharmaceuticals,
Biogen,
Jcr Pharmaceuticals,
Seaport Therapeutics.
Acumen Pharmaceuticals, Inc.'s support email address is info@acumenpharm.com
Acumen Pharmaceuticals, Inc.'s categories are Biotechnology Research
